Moderna’s COVID-19 Vaccine Shows Similar Immune Response in Old and Young

Read Time:32 Seconds

Moderna Inc said on Wednesday that an analysis of the early-stage data of its experimental COVID-19 vaccine showed it induced immune responses in older adults that were similar to those in younger participants. The company has so far enrolled over 13,000 participants in the late-stage trial. About 18% of the total participants are from minority groups that are the hardest hit by the pandemic. Moderna, which has no drugs on the market, has received nearly $1 billion from the U.S. government under Operation Warp Speed. It has also struck a $1.5 billion supply agreement with the United States.

Source: Reuters

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
27770cookie-checkModerna’s COVID-19 Vaccine Shows Similar Immune Response in Old and Young